(Q79222958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

poliovirus

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Patricia N Fultz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jackie Stallworth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Miroslav Novak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Marie J Anderson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Casey D Morrow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

425-437

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

DNA vaccination with the human immunodeficiency virus type 1 SF162DeltaV2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8(+) T-cell-depleted rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and C

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Diversity considerations in HIV-1 vaccine selection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the central nervous system without pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Immunization for long-term protection against AIDS using the macaque model

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Strategies for an HIV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Biological considerations in the development of a human immunodeficiency virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Poliovirus spreads from muscle to the central nervous system by neural pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Evaluation of cell-free and cell-associated peripheral blood human immunodeficiency virus type 1 RNA response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Recombinant rabies virus as potential live-viral vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Immune control of HIV: the obstacles of HLA and viral diversity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900546-4

7 January 2021

10.1016/S0042-6822(03)00546-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585346%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference